Meta AnalysisID 1854
铬和肉桂对2型糖尿病患者血糖和血脂谱的影响：临床试验系统评价与Meta分析
CRD42022311837
Is cinnamon (Cinnamomum zeylanicum) or chromium supplementation effective in improving glycemic and lipid profile in type 2 diabetes mellitus patients? P: Patients with type 2 diabetes mellitus. I: Consumption and / or
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 1854
- Evidence Id
- 10412
- Core Evidence Id
- 10412
- Source Meta Analysis Id
- 1797
- Herb2 Meta Analysis Id
- HBMA001797
- Crd Id
- CRD42022311837
- Title
- Effect of chromium and cinnamon on glycemic and lipid profile of patient with type 2 diabetes mellitus. A systematic review and meta-analysis of clinical trials.
- Review Question
- Is cinnamon (Cinnamomum zeylanicum) or chromium supplementation effective in improving glycemic and lipid profile in type 2 diabetes mellitus patients? P: Patients with type 2 diabetes mellitus. I: Consumption and / or Supplementation of cinnamon (Cinnamomum zeylanicum) or chromium supplementation + standard care. C: No intervention (Standard care). O: Type 2 diabetes mellitus Indicators.
- Study Type Included
- Types of studies included: Randomized control trials Randomized control trials doble blind, single blid, crossover Prospective cohorts
- Condition Being Studied
- Type 2 Diabetes Mellitus Cinnamon (Cinnamomum zeylanicum) consumption or supplementation for adults with type 2 diabetes mellitus. Chromium consumption or supplementation for adults with type 2 diabetes mellitus.
- Participant
- Inclusion criteria: Adults over the age of 18 with a diagnosis of type 2 diabetes with or without obesity. Exclusion criteria: Adults with type 1 diabetes, pediatric patients, patients with metabolic syndrome, gestational diabetes.
- Animal
- Human Disease Modelled
- Intervention
- Intervention: Cinnamon consumption or supplementation, or Chromium consumption or supplementation with or without medication related to type 2 diabetes mellitus.
- Comparator Control
- Placebo or treatment with or without active medications, such as insulin, oral hypoglycaemic agents.
- Main Outcome
- Postprandial blood glucose, serum insulin, HOMA-IR, glycated haemoglobin A1c , fasting blood glucose, fasting blood sugar, advanced glycation end products (AGE), insulin sensitivity and insulin resistance, total cholesterol, low-density lipoprotein, high-density lipoprotein and triglycerides. Measures of effect More than four weeks of consumption and / or supplementation.
- Outcome Measure
- Additional Outcome
- Reducing nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB), Sirtuins, Interleukin 6, Tumor necrosis factor alpha (TNF-α) and superoxide dismutase, glutathione peroxidase, catalase, malondialdehyde, total antioxidant capacity, high sensitive-C-reactive protein, and anthropometric profile. Measures of effect Four or more weeks of consumption and / or supplementation.
- Study Method
- Systematic review
- Keyword
- Chromium; Cinnamomum zeylanicum; Diabetes Mellitus, Type 2; Glycated Hemoglobin A; Humans; Lipids
- Contact
- Dr. Sofía Lorena Bohórquez Medina [email protected]
- Organisational Affiliation
- Universidad San Ignacio de Loyola Universidad Peruana de Ciencias Aplicadas https://www.usil.edu.pe/?verified=true
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- Peru
- Review Stage
- Review Ongoing
- First Submission Date
- 2022-02-19
- Registration Date
- 2022-03-22
- Anticipated Start Date
- 2021-12-09
- Anticipated Completion Date
- 2022-09-30
- Title Cn
- 铬和肉桂对2型糖尿病患者血糖和血脂谱的影响：临床试验系统评价与Meta分析
- Title En
- Effect of chromium and cinnamon on glycemic and lipid profile of patient with type 2 diabetes mellitus. A systematic review and meta-analysis of clinical trials.
- Bilingual Status
- complete